The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Sep. 10, 2024

Filed:

Aug. 12, 2021
Applicant:

Gliknik Inc., Baltimore, MD (US);

Inventors:

David S. Block, Baltimore, MD (US);

Henrik Olsen, Baltimore, MD (US);

Assignee:

Gliknik Inc., Baltimore, MD (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 39/395 (2006.01); A61K 31/573 (2006.01); A61K 45/06 (2006.01); A61P 37/00 (2006.01); C07K 14/47 (2006.01); C07K 16/00 (2006.01); A61K 39/00 (2006.01);
U.S. Cl.
CPC ...
C07K 14/47 (2013.01); A61K 31/573 (2013.01); A61K 39/395 (2013.01); A61K 45/06 (2013.01); A61P 37/00 (2018.01); C07K 16/00 (2013.01); A61K 2039/505 (2013.01); C07K 2317/35 (2013.01); C07K 2317/52 (2013.01); C07K 2317/92 (2013.01); C07K 2319/30 (2013.01); C07K 2319/73 (2013.01); C07K 2319/735 (2013.01);
Abstract

The current invention involves a series of fully recombinant multimerized forms of immunoglobulin Fc which thereby present polyvalent immunoglobulin Fc to immune cell receptors. The fusion proteins exist as both homodimeric and highly ordered multimeric fractions, termed stradomers. In comparison to the homodimeric fraction, purified multimeric stradomers have higher affinity and avidity for FcγRs with slower dissociation and are useful in the treatment and prevention of disease. The current invention demonstrates that directly linking IgG1 Fc regions to multimerization domains leads to enhanced multimerization and biological activity.


Find Patent Forward Citations

Loading…